Protagonist Therapeutics Inc

PTGX NASDAQ Santé & Biotech États-Unis US74366E1029
94.50 $
5.08 %

Protagonist Therapeutics développe des peptides thérapeutiques pour traiter des maladies avec des besoins médicaux non satisfaits, notamment en gastroentérologie et en hématologie.

Price history of Protagonist Therapeutics Inc
Price history of Protagonist Therapeutics Inc

Performance & Momentum

6 Months 10.35 %
1 Year 88.43 %
3 Years 243.76 %
5 Years 171.47 %

Similar stocks to Protagonist Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone